{
"NDC": {
"NDCCode": "51662-1659-2",
"PackageDescription": "2 VIAL, SINGLE-DOSE in 1 CARTON (51662-1659-2) / .1 mL in 1 VIAL, SINGLE-DOSE (51662-1659-1) ",
"NDC11Code": "51662-1659-02",
"ProductNDC": "51662-1659",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Naloxone Hydrochloride",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Naloxone Hydrochloride",
"DosageFormName": "SPRAY",
"RouteName": "NASAL",
"StartMarketingDate": "20230730",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA211951",
"LabelerName": "HF Acquisition Co LLC, DBA HealthFirst",
"SubstanceName": "NALOXONE HYDROCHLORIDE",
"StrengthNumber": "4",
"StrengthUnit": "mg/.1mL",
"Pharm_Classes": "Opioid Antagonist [EPC], Opioid Antagonists [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-06-01",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20230730",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}